Search

Saved Activities

 x 

0 Activities
0 Activities

Recommend to a friend

Considering Biosimilars in Patients Failing their Initial Biologic

Upon completion of the activity, participants should be able to explain the circumstances under which it is appropriate to initiate or switch a patient with a rheumatologic disease to a biosimilar.
IL-rheum-case3

The France Foundation

A ACCME Accredited provider.

The France Foundation ©

Chandler Building, 84 Lyme Street, Old Lyme, CT USA